MDT

88.96

+0.59%↑

VEEV

226.47

-0.52%↓

A

115.98

+2.05%↑

HQY

88.73

+1.89%↑

PDCO

31.27

+0.06%↑

MDT

88.96

+0.59%↑

VEEV

226.47

-0.52%↓

A

115.98

+2.05%↑

HQY

88.73

+1.89%↑

PDCO

31.27

+0.06%↑

MDT

88.96

+0.59%↑

VEEV

226.47

-0.52%↓

A

115.98

+2.05%↑

HQY

88.73

+1.89%↑

PDCO

31.27

+0.06%↑

MDT

88.96

+0.59%↑

VEEV

226.47

-0.52%↓

A

115.98

+2.05%↑

HQY

88.73

+1.89%↑

PDCO

31.27

+0.06%↑

MDT

88.96

+0.59%↑

VEEV

226.47

-0.52%↓

A

115.98

+2.05%↑

HQY

88.73

+1.89%↑

PDCO

31.27

+0.06%↑

STERIS PLC

Затворен

СекторЗдравеопазване

227.86 1.11

Преглед

Промяна на цената на акция

24 ч

Текуща

Минимум

222.03

Максимум

228.11

Ключови измерители

By Trading Economics

Приходи

16M

173M

Продажби

42M

1.4B

P/E

Средно за сектора

36.498

63.778

EPS

2.32

Дивидентна доходност

1.01

Марж на печалбата

12.643

Служители

18,000

EBITDA

-85M

245M

Препоръки

By TipRanks

Препоръки

Купи

12-месечна прогноза

+16.45% upside

Дивиденти

By Dow Jones

Дивидентна доходност

Средно за сектора

1.01%

2.39%

Следващи печалби

7.05.2025 г.

Следваща дата на дивидент

25.06.2025 г.

Следваща дата на екс-дивидент

11.06.2025 г.

Пазарни показатели

By TradingEconomics

Пазарна капитализация

22B

Предишно отваряне

226.75

Предишно затваряне

227.86

Настроения в новините

By Acuity

26%

74%

73 / 386 Класиране в Healthcare

Техническа оценка

By Trading Central

Увереност

Strong Bullish Evidence

STERIS PLC Графика

Миналото представяне не гарантира бъдещи резултати.

Свързани новини

5.02.2025 г., 21:35 ч. UTC

Печалби

Steris: Outlook Does Not Reflect Any Potential Impact From New Tariffs >STE

5.02.2025 г., 21:34 ч. UTC

Печалби

Steris: FY25 Guidance Change Is Primarily Due to Currency >STE

5.02.2025 г., 21:34 ч. UTC

Печалби

Steris Cuts FY25 Revenue View to Increase of About 6% From Prior View for 6.5%-7%>STE

5.02.2025 г., 21:33 ч. UTC

Печалби

Steris 3Q EPS $1.75 >STE

5.02.2025 г., 21:30 ч. UTC

Печалби

Steris Sees FY Adj EPS $9.05-Adj EPS $9.15 >STE

5.02.2025 г., 21:30 ч. UTC

Печалби

Steris 3Q Rev $1.4B >STE

5.02.2025 г., 21:30 ч. UTC

Печалби

Steris 3Q Adj EPS $2.32 >STE

6.11.2024 г., 21:41 ч. UTC

Печалби

Steris Backs FY25 Revenue Up 6.5%-7.5% >STE

6.11.2024 г., 21:40 ч. UTC

Печалби

Steris 2Q EPS $1.51 >STE

6.11.2024 г., 21:30 ч. UTC

Печалби

Steris Sees FY Adj EPS $9.05-Adj EPS $9.25 >STE

6.11.2024 г., 21:30 ч. UTC

Печалби

Steris 2Q Adj EPS $2.14 >STE

6.11.2024 г., 21:30 ч. UTC

Печалби

Steris 2Q Rev $1.3B >STE

6.08.2024 г., 20:36 ч. UTC

Печалби

Steris 1Q Adj EPS $2.03 >STE

6.08.2024 г., 20:30 ч. UTC

Печалби

Steris 1Q Net $139.9M >STE

6.08.2024 г., 20:30 ч. UTC

Печалби

Steris 1Q EPS $1.41 >STE

6.08.2024 г., 20:30 ч. UTC

Печалби

Steris Sees FY Adj EPS $9.05-Adj EPS $9.25 >STE

3.06.2024 г., 11:03 ч. UTC

Придобивния, сливания и поглъщания

PEAK ROCK Cap Affil COMPLETES PREVIOUSLY ANNOUNCED ACQUISITION of HUFRIEDYGROUP

31.05.2024 г., 20:47 ч. UTC

Придобивния, сливания и поглъщания

Steris Completes $787.5M Sale of Dental Segment to Peak Rock Capital

8.05.2024 г., 20:40 ч. UTC

Печалби

Steris Sees FY25 Adj EPS $9.05-Adj EPS $9.25 >STE

8.05.2024 г., 20:39 ч. UTC

Печалби

Steris: Plan Includes Restructuring of the Healthcare Surgical Business in Europe >STE

8.05.2024 г., 20:39 ч. UTC

Печалби

Steris Announcing a Targeted Restructuring Plan >STE

8.05.2024 г., 20:39 ч. UTC

Печалби

Steris 4Q EPS $3.81 >STE

8.05.2024 г., 20:30 ч. UTC

Печалби

Steris 4Q Adj EPS $2.58 >STE

11.04.2024 г., 11:01 ч. UTC

Придобивния, сливания и поглъщания

Steris Expects Resulting Benefit of Reduction in Interest Expense to Be About $0.35 Per Shr >STE

11.04.2024 г., 11:00 ч. UTC

Придобивния, сливания и поглъщания

Steris: Transaction Is Anticipated to Close in 1Q of Fiscal Yr 2025 >STE

11.04.2024 г., 10:59 ч. UTC

Придобивния, сливания и поглъщания

Steris: Transaction Terms Include Opportunity to Receive Additional Earnout of Up to $12.5M >STE

11.04.2024 г., 10:59 ч. UTC

Придобивния, сливания и поглъщания

Steris: Transaction Is Structured as Equity Sale >STE

11.04.2024 г., 10:58 ч. UTC

Придобивния, сливания и поглъщания

Steris Enters Agreement to Divest Dental Segment to Peak Rock Cap for $787.5M >STE

11.04.2024 г., 10:58 ч. UTC

Придобивния, сливания и поглъщания

STERIS to Sell Dental Segment to an Affiliate of Peak Rock Capital for $787.5M

Сравнение с други в отрасъла

Ценова промяна

STERIS PLC Прогноза

Ценова цел

By TipRanks

16.45% нагоре

12-месечна прогноза

Среден 265 USD  16.45%

Висок 265 USD

Нисък 265 USD

Според 3 анализатори от Wall Street, предложили 12-месечна ценова цел за STERIS PLC през последните три месеца.

Консенсусна оценка

By TipRanks

Купи

3 ratings

2

Купи

1

Задържане

0

Продай

Техническа оценка

By Trading Central

222.25 / 228.22Подкрепа & съпротива

Краткосрочен план

Strong Bullish Evidence

Средносрочен план

Strong Bullish Evidence

Дългосрочен план

Weak Bullish Evidence

Настроение

By Acuity

73 / 386 Класиране в Здравеопазване

Настроения в новините

Бичи доказателства

Волатилност

Под средното

Обем новини (RCV)

Под средното

Финанси

Продажбени и админисративни разходи

Оперативни разходи

Печалба преди облагане с данъци

Продажби

Разходи за продажби

Брутна печалба от продажби

Разходи за лихви по дълг

EBITDA

Оперативна печалба

$

Относно STERIS PLC

STERIS plc provides infection prevention products and services worldwide. It operates through three segments: Healthcare, Applied Sterilization Technologies (AST), and Life Sciences. The Healthcare segment offers cleaning chemistries and sterility assurance products; automated endoscope reprocessing system and tracking products; endoscopy accessories, washers, sterilizers, and other pieces of capital equipment for the operation of a sterile processing department; and equipment used directly in surgical tables, lights, and connectivity solutions, as well as equipment management services. It also provides capital equipment installation, maintenance, upgradation, repair, and troubleshooting services; preventive maintenance programs and repair services; instrument, devices, and endoscope repair and maintenance services; and custom process improvement consulting and outsourced instrument sterile processing services. The AST segment provides contract sterilization and testing services for medical device and pharmaceutical manufacturers through a network of contract sterilization and laboratory facilities, as well as integrated sterilization equipment and control systems to medical device manufacturers and research institutions. The Life Sciences segment designs, manufactures, and sells consumable products, such as pharmaceutical detergents, cleanroom disinfectants and sterilants, pharmaceutical grade and research sterilizers and washers, sterility assurance and maintenance products, vaporized hydrogen peroxide room decontamination systems and sterilizers, and high purity water and pure steam generators. This segment also offers equipment installation, maintenance, upgradation, repair, and troubleshooting services; and preventive maintenance programs and repair services. It serves its products and services to hospitals, other healthcare providers, and pharmaceutical manufacturers. The company was founded in 1985 and is headquartered in Mentor, Ohio.